Medical News

Antiretroviral Treatment Helps Reduce TB in HIV Patients in South Africa: Study

December 20, 2013

This article was reported by SABC (Johannesburg).

An article in SABC said a University of Cape Town (UCT) study conducted on adults enrolled in a public sector treatment program in the Free State, South Africa, found that antiretroviral (ARV) treatments assisted in reducing incidents of TB in HIV-positive individuals as well as the mortality of those infected with both diseases. According to UCT Researcher Vanessa Timmerman, "ARV is so highly effective in reducing the incidence of TB in these patients and also reducing mortality in this group of patients." However, approximately 13 million HIV-positive Africans do not have access to the required medications. Earlier this month, the World AIDS Campaign told an African AIDS conference that individuals in West and Central Africa are the worst affected by HIV/AIDS, but only a third have access to treatment.

Back to other news for December 2013

This information was reprinted from with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.